HRV Global Life Sciences Strengthens Global Presence at DCAT Week 2025 in New York

▴ HRV Global Life Sciences
Its strong global network and focus on innovation enable the company to support this growth and meet the evolving needs of the pharmaceutical industry.
Hyderabad, 25 March 2025 — HRV Global Life Sciences, a leading provider of innovative solutions for the pharmaceutical and life sciences industry,  participated in DCAT Week 2025, the premier event for the global bio/pharmaceutical manufacturing value chain. Held in New York, the event brought together industry leaders, innovators, and decision-makers from around the world to discuss emerging trends, forge strategic partnerships, and drive advancements in pharmaceutical development and manufacturing.
Attending DCAT Week 2025 provided HRV Global Life Sciences’ with a valuable platform to explore new business opportunities and forge new partnerships with US industry influencers. As one of the leaders in the virtual pharma segment, the company is setting new benchmarks in the industry through its innovative approach to pharmaceutical manufacturing and distribution. The company has a pipeline of over 25 products to be launched in US and European markets in the current year.
India's pharmaceutical industry, valued at around USD 55 billion, is expected to grow 2.2 to 2.4 times over the next six years, reaching USD 120 billion to USD 130 billion by 2030. HRV Global Life Sciences is well-positioned to drive India's transition from a volume-based exporter to a leader in high-value products, reinforcing its position in the global pharmaceutical market.
Speaking on the participation, Mr. Hari Kiran Chereddi, Managing Director of HRV Global Life Sciences, said, “DCAT Week 2025 provided an incredible platform for HRV Global Life Sciences to connect with industry leaders, exchange valuable insights, and strengthen our global partnerships. We had productive discussions on the evolving needs of the industry. We identified new opportunities for collaboration that will help drive innovation, facilitate global market expansion, and reinforce India’s position as a key player in the international pharmaceutical landscape.”
With India's pharmaceutical sector driving the country's economic growth, HRV Global Life Sciences is well-positioned to capitalise on this momentum. Its strong global network and focus on innovation enable the company to support this growth and meet the evolving needs of the pharmaceutical industry.
About HRV Global Life Sciences
HRV Global Life Sciences, established in 2015 and headquartered in Hyderabad, India, is a leading manufacturer and supplier of APIs, intermediates, and pharmaceutical additives. The company has a strong global presence with offices in the USA, Switzerland, Dubai, Lithuania, and Turkey, serving over 100 corporations worldwide. HRV partners with more than 55 Indian drug substance manufacturers, focusing on markets in Europe, the US, and the Middle East.
Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Smart Operating Rooms: The Future of Hospital OTNovember 21, 2026
Smartphone Diagnostics: Phones as Medical Screening ToolsNovember 21, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
Hospital-at-Home in India: Can Technology Deliver Safe Care?November 20, 2026
Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026